SteelPeak Wealth LLC lessened its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 8.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 67,651 shares of the company's stock after selling 6,296 shares during the period. SteelPeak Wealth LLC's holdings in Procter & Gamble were worth $11,342,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Dana Investment Advisors Inc. boosted its position in Procter & Gamble by 3.0% during the 2nd quarter. Dana Investment Advisors Inc. now owns 38,429 shares of the company's stock valued at $6,338,000 after acquiring an additional 1,125 shares in the last quarter. RiverFront Investment Group LLC boosted its position in shares of Procter & Gamble by 2.7% during the second quarter. RiverFront Investment Group LLC now owns 26,383 shares of the company's stock valued at $4,351,000 after buying an additional 698 shares during the last quarter. Strategic Investment Solutions Inc. IL purchased a new position in shares of Procter & Gamble during the second quarter valued at approximately $1,782,000. Centennial Bank AR lifted its holdings in shares of Procter & Gamble by 4.6% during the 2nd quarter. Centennial Bank AR now owns 2,435 shares of the company's stock valued at $403,000 after buying an additional 108 shares during the period. Finally, Brown Financial Advisors purchased a new position in Procter & Gamble in the second quarter worth about $2,003,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Up 0.7 %
Shares of NYSE PG traded up $1.20 during trading hours on Thursday, hitting $167.43. 4,132,883 shares of the stock were exchanged, compared to its average volume of 7,479,979. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43. The firm has a fifty day moving average price of $168.65 and a 200-day moving average price of $169.39. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. The company has a market cap of $394.31 billion, a PE ratio of 26.66, a PEG ratio of 3.69 and a beta of 0.45.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. The business had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. Procter & Gamble had a return on equity of 32.88% and a net margin of 18.35%. The company's quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the company earned $1.84 earnings per share. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be issued a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. Procter & Gamble's dividend payout ratio (DPR) is presently 64.17%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on PG shares. UBS Group decreased their target price on Procter & Gamble from $196.00 to $189.00 and set a "buy" rating on the stock in a report on Thursday, January 16th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 price target on shares of Procter & Gamble in a research note on Thursday, January 23rd. DA Davidson reiterated a "buy" rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a research report on Thursday, January 16th. Finally, Hsbc Global Res raised shares of Procter & Gamble to a "strong-buy" rating in a research note on Friday, October 4th. Eight research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $180.53.
Get Our Latest Analysis on PG
Insider Activity at Procter & Gamble
In related news, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the transaction, the insider now directly owns 172,814 shares of the company's stock, valued at approximately $28,313,845.76. This trade represents a 34.36 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares of the company's stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 151,097 shares of company stock worth $25,635,076 over the last three months. Company insiders own 0.18% of the company's stock.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report